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Glucose levels in mammals are tightly controlled
through multiple mechanisms to meet systemic en-
ergy demands. Downregulation of hepatic glucoki-
nase (GCK) during fasting facilitates the transition
of the liver from a glucose-consuming to a gluconeo-
genic organ. Here, we report the transcriptional regu-
lation of hepatic GCK by a long non-coding RNA
(lncRNA) named liver GCK repressor (lncLGR).
lncLGR is induced by fasting, and physiological over-
expression of lncLGR to mimic fasting levels effec-
tively suppresses GCK expression and reduces
hepatic glycogen content in mice. Consistently,
lncLGR knockdown enhances GCK expression and
glycogen storage in fasted mice. Mechanistically,
lncLGR specifically binds to heterogenous nuclear
ribonucleoprotein L (hnRNPL), which is further
confirmed to be a transcriptional repressor of GCK
in vivo. Finally, we demonstrate that lncLGR facili-
tates the recruitment of hnRNPL to the GCK pro-
moter and suppresses GCK transcription. Our data
establish a lncRNA-mediated mechanism that regu-
lates hepatic GCK expression and glycogen deposi-
tion in a physiological context.
INTRODUCTION
Although only 1.5%of the human genomeencodes proteins,ma-
jor sequencing efforts in the past decade have revealed that there
is a vast repertoire of uncharacterized non-coding RNAs in the
human transcriptome (Djebali et al., 2012; Harrow et al., 2012).
Among all non-coding RNA species, the most abundant, and
possibly also the least understood, is that comprised of long
non-coding RNAs (lncRNAs), which are transcripts that are at
least 200 nt long and have no coding potential. lncRNAs have
been demonstrated to regulate diverse cellular processes
ranging from gene transcription, RNA stability, and translation
control (Mora´n et al., 2012; Wang and Chang, 2011), but only a
small fraction of them have been investigated in a physiologically
relevant context. Conceptually, it is straightforward to envisionCethat some of these lncRNAs might function as regulators of en-
ergymetabolism in vivo, which is essentially connected to all ma-
jor biological processes (Kornfeld andBr€uning, 2014). Indeed,we
have recently identified that a liver-enriched lncRNA, lncLSTR,
robustly regulates triglyceride uptake in mice (Li et al., 2015).
As a central metabolic organ, the liver also plays an important
role in maintaining glucose homeostasis. The liver produces
glucose through glycogenolysis and gluconeogenesis during
fasting, while promoting glucose uptake and glycogen storage
during feeding. A key enzyme in the liver, glucokinase (GCK), dic-
tates the direction of hepatic glucose flux, and GCK expression
and activity are subject to exquisite regulation (Massa et al.,
2011). In the postprandial period, the rise in glucose and insulin
increases GCK activity, whereas in the fasting state, the com-
bined decrease in glucose and insulin concentrations and in-
crease in glucagon concentrations, decrease GCK activity. The
underlying molecular mechanisms regulating GCK expression
during feeding cycles are complex at both transcriptional and
post-transcriptional levels (Massa et al., 2011). After a meal, in-
sulin upregulates GCK transcription through a PI3K-PKB
pathway, and several transcription factors including HNF4a,
HIF1a, SREBP1c, and LRH-1 have been implicated in this pro-
cess (Foretz et al., 1999; Roth et al., 2004). However, much
less is known about how GCK expression is downregulated dur-
ing fasting, and one assumption is that reduced insulin levels
during fasting lead to the suppression of GCK transcription.
In this report, we characterize a fasting-induced lncRNA in the
liver that we have named liver GCK repressor (lncLGR), which
suppresses GCK transcription in vivo by interacting with
hnRNPL, an RNA-binding protein that has no previously known
role in regulating glucose metabolism. Our results provide a
lncRNA-mediated mechanism for the regulation of GCK activity
and hepatic glycogen storage and further solidify the functional
significance of lncRNAs in maintaining metabolic homeostasis.
RESULTS
Hepatic Overexpression of lncLGR Suppresses GCK
Expression and Decreases Glycogen Content in Mouse
Liver
lncLGR is a full-length cDNA clone deposited in Fantom3 data-
base as 4632424N07 and in GenBank as AK028540. It is an inter-
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genome, and lncLGR transcripts could be detected in multiple
tissues in mice with low abundance (Figure S1A). The copy num-
ber of lncLGR in isolated primary hepatocytes is about 3.6
copies per cell (Figure S1B). We initially found that lncLGR
expression in mouse liver was significantly induced by fasting
and recovered after refeeding (Figure 1A). Stability analysis
showed that lncLGR has a half-life time of approximate 8 hr in
primary hepatocytes (Figure S1C). To further study the regulation
of lncLGR by metabolic hormones and nutrients, we treated
mouse primary hepatocytes with insulin, glucagon, or glucose
and quantified lncLGR expression levels. As shown in Fig-
ure S1D, while glucose or glucagon had no significant effect, in-
sulin alone could suppress lncLGR expression by nearly 50%.
Thus, lncLGR appears to be a fasting-induced and insulin-regu-
lated lncRNA, suggesting a functional role in glucose and lipid
metabolism. To identify the potential metabolic functions of
lncLGR in vivo, we first overexpressed lncLGR in mouse liver us-
ing an adenoviral system, which increased the hepatic lncLGR
levels by 80% (Figure 1B) in mice with a 4 hr food withdrawal,
resembling the levels under fasting conditions (Figure 1A). While
there was no significant difference in plasma glucose between
lncLGR overexpression (OE) and control mice, plasma triglycer-
ide (TG) levels were moderately, but significantly lower (10%
reduction) in the lncLGR OE group (Figures S1E and S1F).
Further biochemical analyses revealed that glycogen and TG
contents in the liver were both decreased in lncLGR OE mice
compared with controls (Figures 1C and 1D). The simultaneous
decrease of glycogen and TG contents in the liver led us to hy-
pothesize that lncLGR overexpression could limit the availability
of glucose-6-phosphate (G6P) for glycogen synthesis and de
novo lipogenesis. Consistently, hepatic G6P levels were signifi-
cantly lower in lncLGR OE mice compared with controls (Fig-
ure 1E). Since hepatic GCK could directly determine G6P levels
in the liver, we next analyzed GCK expression and found that the
GCK mRNAs were significantly decreased in lncLGR OE mice,
while the expression levels of all three remaining hexokinases
were not changed (Figure 1F). Expression levels of key genes
in lipogenesis, glucose, and glycogen metabolism were also
similar between the two groups of mice as well (Figures S1G
and S1H). We further confirmed that there were decreased
GCK protein levels as well as GCK enzymatic activity in lncLGR
OE mice (Figures 1G and 1H). Taken together, these data sug-
gest that lncLGR may regulate hepatic glucose metabolism by
downregulating GCK expression.
To definitively test whether GCK is the primary mechanism
responsible for the reduced hepatic glycogen content in lncLGR
OEmice, we co-administeredGCK adenoviruses into thesemiceFigure 1. Overexpression of LncLGR Suppresses GCK Expression and
(A) Expression levels of lncLGR in the livers of mice (n = 4) fed ad libitum (Ad Libi
refeeding (Refeed).
(B) Expression levels of lncLGR in the livers of control (Ad-vector) and lncLGR O
(C–F) Liver TG content (C), liver glycogen content (D), liver G6P content (E), and live
food withdrawal.
(G) GCK protein levels in the livers of control and lncLGROEmice (n = 4). The inten
right.
(H) Relative GCK activity in the livers of control and lncLGR OE mice (n = 6).
(I and J) Relative GCK activity (I) and glycogen levels (J) in the livers of mice receiv
adenoviruses (Ad-GCK) after a 4 hr food withdrawal (n = 6). The error bars repre
Ceat a dose that is sufficient to rescue the reduced GCK activity
(Figure 1I) and demonstrated that the decreased liver glycogen
content caused by lncLGR overexpression was also completely
reversed in these mice (Figure 1J). These data strongly support
that the GCK effects are the primary mechanism by which
lncLGR regulates hepatic glycogen storage.
Depletion of Hepatic lncLGR Results in Increased GCK
Expression and Glycogen Storage in Fasted Mice
Since GCK expression is upregulated by feeding and downregu-
lated by fasting in vivo, it is plausible that one of the physiological
roles for fasting-induced lncLGR is to suppress GCK expression.
We used a loss-of-function approach to further interrogate this
hypothesis. Mice injected with recombinant adenoviruses that
carry a lncLGR-targeting short hairpin (sh)RNA showed a
40% reduction in hepatic lncLGR levels after an overnight
fast (Figure 2A). This system allows us to investigate hepatic
glucose metabolism in the fasting condition when lncLGR is
physiologically induced. Consistent with the effects seen in the
gain-of-function model, lncLGR knockdown (KD) significantly
increasedGCK expression at bothmRNA and protein levels (Fig-
ures 2A and 2B). Consistently, hepatic G6P levels were also
significantly increased in lncLGRKDmice comparedwith control
mice receiving lacZ-targeting shRNA adenoviruses (Figure 2C).
In addition, while mice in the control group exhibited almost
complete depletion of glycogen storage in the liver after an over-
night fast, lncLGR KD mice retained significantly higher hepatic
glycogen levels (Figure 2D). These findings support that sup-
pression of GCK expression by lncLGR might play an essential
role in regulating hepatic glucose metabolism during fasting.
lncLGR Binds to hnRNPL, which Functions as a
Repressor of GCK Expression
We next sought to explore the molecular mechanism by which
lncLGR regulates GCK expression. We fractionated mouse liver
tissue samples and found that lncLGR is mainly localized in the
nucleus (Figure 3A), suggesting a potential role in gene transcrip-
tion. To identify protein-binding partners of lncLGR in the
nucleus, we performed an RNA pull-down assay using nuclear
extracts from liver tissue samples and analyzed proteins specif-
ically bound to lncLGR using mass spectrometry (Figure 3B).
One of these proteins was hnRNPL, which we could further
confirm to bind specifically to lncLGR by anti-hnRNPL immuno-
blotting (Figure 3B). Subsequently, we performed a reciprocal
pull down of hnRNPL using nuclear extracts of liver tissue sam-
ples and quantified RNAs in the immunoprecipitates by quantita-
tive real-time PCR. In this experiment, lncLGR was enriched byGlucose Metabolism in Mouse Livers
tum), subject to a 24 hr fast (Fast), or subject to a 24 hr fast followed by a 4 hr
E (Ad-lncLGR) mice (n = 6) after a 4 hr food withdrawal.
r gene expression levels (F) in control and lncLGROEmice (n = 5–7) after a 4 hr
sities of bands were quantified and normalized to actin levels, as shown on the
ing control, lncLGR overexpression, or both lncLGR and GCK overexpression
sent SEM and *p < 0.05.
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Figure 2. lncLGR KD Results in Increased GCK Expression and Glycogen Storage in Mouse Livers during Fasting
(A) Gene expression levels in the livers of control (Ad-sh lacZ) and lncLGR KD (Ad-sh lncLGR) mice (n = 6) after a 16 hr food withdrawal.
(B) GCK protein levels in the livers of control and lncLGR KD mice (n = 4). The intensities of bands were quantified and normalized to actin levels, as shown on
the right.
(C) Total G6P content in the livers (n = 5) of control and lncLGR KD mice was quantified using a colorimetric assay system.
(D) Total glycogen content in the livers (n = 6) of control and lncLGR KDmice was quantified using a colorimetric assay system. The error bars represent SEM and
*p < 0.05.23-fold as compared to an IgG control or lncLSTR (Li et al.,
2015), a nuclear lncRNA in mouse liver that we have recently
demonstrated to be a regulator of systemic lipid metabolism in
mice (Figure 3C). Furthermore, an in vitro binding assay using
transcribed lncLGR RNAs and purified hnRNPL proteins also
supports that they directly interact to form an RNP complex (Fig-
ure 3D). To determine if hnRNPL regulates GCK expression
in vivo, we knocked down hnRNPL in mouse liver and found
that a 50% reduction of hnRNPL could significantly increase
GCK expression at both the mRNA and protein levels (Figures
3E and 3F), indicating that hnRNPL could function as a repressor
of GCK expression in mouse liver.
Next, we set up experiments to test if the effects of lncLGR on
glucosemetabolismare dependent on its bindingwith hnRNPL. It
has been established that hnRNPL often binds to RNAs through
specific interactions with CA repeats in the transcripts (Zhang
et al., 2013). Interestingly, lncLGR contains a 21-CA repeat near
its 50 end, which we hypothesized is required for its binding1870 Cell Reports 14, 1867–1875, March 1, 2016 ª2016 The Authorswith hnRNPL. To test this, we first deleted 50 335 nucleotides of
lncLGR including the CA repeat and demonstrated by a RNA
pull-down assay that the truncated lncLGRwithout theCA repeat
exhibited drastically decreased, although not completely abol-
ished, binding with hnRNPL compared to the full-length one (Fig-
ure 3G). Next, we tested if this shorter lncLGR with impaired
hnRNPL binding capacity could still suppress GCK expression
in mice. Adenovirus-mediated overexpression of the truncated
lncLGR clearly lost the ability to suppress GCK expression as
well as the effects on glycogen levels (Figures 3H and 3I). These
data unambiguously support that lncLGR-mediated regulation of
GCKexpression andglycogencontent dependson the functional
complex formed by lncLGR and hnRNPL.
lncLGR and hnRNPL Coordinately Suppress GCK
Transcription
Since lncLGR interacts with hnRNPL, and either of them sup-
presses GCK expression, we next attempted to understand if
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Figure 3. lncLGR Binds to hnRNPL, which Functions as a Repressor of GCK Transcription
(A) Levels of lncLGR in whole cell, cytosolic, or nuclear fractions of liver tissue samples pooled from four mice (result of an independent experiment is also shown
in Figure S2A).
(legend continued on next page)
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and how they coordinate this regulation. We first performed a
GCK promoter-driven luciferase reporter assay in HEK293 cells
and found that under the condition when overexpression of
either lncLGR or hnRNPL alone at a dose with no or moderate,
but significant, effects on GCK promoter activity respectively,
their co-overexpression strongly suppresses GCK promoter ac-
tivity by 50% suggesting that lncLGR and hnRNPL function syn-
ergistically to regulate GCK transcription (Figure 4A). Consistent
with this observation, HnRNPL has been recently demonstrated
to bind DNA and function as a transcription factor (Li et al., 2014).
The physical and functional interactions between lncLGR and
hnRNPL we observed here also prompted us to hypothesize
that hnRNPL could bind to the GCK promoter and suppress its
transcription, while lncLGR binding would further enhance this
regulation. Consistently, further fractionation of liver nuclei
showed that lncLGR is significantly enriched in chromatin frac-
tion (Figure 4B). A direct binding assay using purified hnRNPL
protein and biotinylated GCK promoter fragments also demon-
strated that hnRNPL directly interacts with the GCK promoter
DNA within the region from around 1,500 bp to 700 bp (Fig-
ure 4C). To further validate this model and examine the specific
binding of endogenous hnRNPL on the mouse GCK promoter
and its regulation by lncLGR in vivo, we simultaneously knocked
down hnRNPL and overexpressed lncLGR inmouse livers by co-
injecting two adenoviruses. We then performed chromatin
immunoprecipitation (ChIP) analysis using an anti-hnRNPL
antibody and found that hnRNPL specifically binds to the GCK
promoter in mouse liver (Figures 4D and 4E). Intriguingly, we
demonstrated that while hnRNPL KD alone reduced its binding
to the GCK promoter, this effect was completely reversed by a
simultaneous lncLGR overexpression (Figure 4D) despite similar
levels of total hnRNPL proteins (Figure 4E). Furthermore, the
increased GCK expression caused by hnRNPL KD was also
completely reversed by lncLGR overexpression (Figure 4F),
a pattern that precisely mirrors the hnRNPL binding levels on
the GCK promoter observed in these mice (Figure 4D). These
results strongly support a model in which lncLGR and hnRNPL
operate synergistically to regulate GCK expression, such that
lncLGR suppresses GCK transcription by facilitating hnRNPL
binding to the GCK promoter.
In summary, our results support that during fasting, lncLGR is
induced in the liver and forms a functional complex with
hnRNPL, which facilitates the recruitment of hnRNPL to the(B) Silver stained SDS-PAGE gel analysis of proteins in nuclear extract of mouse
(YFP-NC) (left). The highlighted regions were analyzed by mass spectrometry, ide
proteins in nuclear extract of liver tissue samples that are bound to biotinylated ln
(C) Anti-hnRNPL immunoblotting analysis of proteins in immunoprecipitates of mo
3-phosphate dehydrogenase (GAPDH), lncLSTR, and lncLGR RNA levels in immu
an independent experiment is also shown in Figure S2B) are shown on the right.
(D) Coomassie blue staining of purified recombinant hnRNPL proteins expressed i
bound to biotinylated lncLGR or a reversed YFP using an anti-hnRNPL antibody
(E) Gene expression levels in the livers of control (Ad-sh lacZ) and hnRNPL KD (A
(F) HnRNPL and GCK protein levels in the livers of control and hnRNPL KDmice (n
shown on the right.
(G) Immunoblotting analysis of nuclear extract of mouse liver tissue samples that
anti-hnRNPL antibody.
(H and I) Gene expression (H) and glycogen levels (I) in the livers of control (Ad-ve
withdrawal. The error bars represent SEM and *p < 0.05.
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GCK (Figure 4G).
DISCUSSION
As a key enzyme controlling liver glucose metabolism, GCK is
subject to robust regulation by hormonal signals associated
with feeding-fasting rhythms, such as insulin and glucagon. Mul-
tiple insulin- and nutrient-activated signaling cascades have
been identified to enhance GCK expression upon feeding
(Massa et al., 2011). In contrast, it remains elusive how GCK is
downregulated during fasting, which is a major physiological
step for the liver to shift from a glucose-consuming state to a glu-
coneogenic one. In this study, we identify a lncRNA-mediated
regulatory mechanism of GCK expression in which a lncRNA
complex formed by lncLGR and hnRNPL suppresses GCK tran-
scription in animals, and this regulationmay allow the liver to pre-
cisely control GCK levels during fasting.
Our work also provides critical insight into the function of
hnRNPL, which belongs to the hnRNP protein family comprised
of over 20 RNA-binding proteins of diverse structure and binding
specifies (Alvarez-Dominguez et al., 2015). In general, hnRNPs
regulate key steps of RNAmetabolism, including pre-mRNA pro-
cessing, RNA transportation, and mRNA degradation (Alvarez-
Dominguez et al., 2015; Chaudhury et al., 2010). Our findings
that liver-specific expression of hnRNPL represses GCK expres-
sion suggest that hnRNPL could carry out tissue-specific func-
tions in energy metabolism. Our data also indicate that hnRNPL
regulates GCK expression through a nonconventional mecha-
nism by directly binding to DNA and functioning as a transcrip-
tional repressor. It has been reported that hnRNPs can regulate
transcription in cells and tissues (Chaudhury et al., 2010). How-
ever, hnRNPs are often abundantly and ubiquitously expressed,
thus begging the question of how they achieve their specificities
in these transcriptional events. lncRNAs that are restricted to
specific tissues or are inducible only by specific stimuli might
provide the answers. These lncRNAs may bind to a subset of
hnRNPs only under specific conditions, conferring temporal
and spatial regulation that allows hnRNPs to bind to a set of
promoters and control transcription in a tissue- and context-
dependent manner. In addition to the lncLGR-hnRNPL complex
shown here, multiple lncRNAs have been reported to engage in
transcriptional regulation by recruiting hnRNPs. For example,liver tissue samples that are bound to biotinylated lncLGR or a reversed YFP
ntifying hnRNPL as a protein unique to lncLGR. The immunoblotting analysis of
cLGR or a reversed YFP using an anti-hnRNPL antibody is shown on the right.
use liver tissue samples using an anti-hnRNPL antibody (left). Glyceraldehyde
noprecipitates of liver tissue samples using an anti-hnRNPL antibody (result of
n HEK293T cells (left). The immunoblotting analysis of purified hnRNPL that are
is shown on the right.
d-sh hnRNPL) mice (n = 5) after a 4 hr food withdrawal.
= 4). The intensities of bands were quantified and normalized to actin levels, as
are bound to biotinylated lncLGR, lncLGR D1–335, or a reversed YFP using an
ctor) and lncLGR D1–335 OE (Ad-lncLGR D1–335) mice (n = 6) after a 4 hr food
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lincRNA-p21 interacts with hnRNPK, which collectively re-
presses p53-dependent transcriptional responses in trans
(Huarte et al., 2010), while activating p53-depedent p21 tran-
scription in cis (Dimitrova et al., 2014). It was also demonstrated
that hnRNPL could regulate TNFa transcription via binding to
lncRNAs in immune cells (Li et al., 2014). Therefore, guiding an
hnRNP to a promoter region might be a general function for
lncRNAs in transcriptional regulation.
Of note, the lncLGR locus in the mouse genome lays very
closely downstream of a protein-coding gene Itga2, suggesting
that the lncLGR transcript could be an isoform of Itga2 tran-
scripts with an extended UTR. However, several lines of evi-
dence suggest that lncLGR is an independent transcript. First,
Itga2 expression is barely detectable in mouse liver. Second,
there is no change in Itga2 expression during fasting and re-
feeding (data not shown), whereas lncLGR is upregulated in
mouse liver by fasting. Third, KD of lncLGR does not change
Itga2 expression levels. Finally, we performed rapid amplifica-
tion of cDNA ends (RACE) using RNAs from mouse hepatic
cell line hepa1-6 and identified that the 50 end of lncLGR is
40 nucleotides shorter than the recorded one, thus placing
the transcription initiation site of lncLGR further downstream
of Itga2 than the GenBank one does. Interestingly, while
lncLGR shares some sequence similarity with 30 UTR of human
ITGA2, the CA repeat required for the efficient interaction be-
tween hnRNPL and lncLGR (Figure 3G) is absent in the
30UTR of human ITGA2, indicating that it might not represent
the orthologous human lncLGR. Nevertheless, we tested the ef-
fect of hnRNPL on the promoter of human liver GCK and found
hnRNPL also suppressed its transcription activity (data not
shown).
It should be noted that the copy number of lncLGR is only 3.6
copies per cell in isolated primary hepatocytes at the basal
level. Considering that hnRNPL is an abundant protein, this
low level of lncLGR seems not able to strongly modify hnRNPL
function. However, our results suggest that lncLGR promotes
rather than sequestering or blocking the recruitment of hnRNPL
to the GCK promoter, where comparable levels of lncLGR to
hnRNPL proteins might not be necessary in order to function.
Instead, the complex formed by lncLGR and a specialized
pool of hnRNPL significantly regulates GCK to generate a func-
tional impact. Although the very low copy number of lncRNAs is
usually linked with cis regulation of gene expression (Dimitrova
et al., 2014), our results support that lncLGR regulates GCK
expression in trans. First, the change of lncLGR expression dur-
ing fasting and refeeding does not associate with expressionFigure 4. lncLGR and hnRNPL Coordinately Suppress GCK Transcript
(A) Mouse liver GCK promoter-driven luciferase activities in HEK293 cells transfec
hnRNPL is a pcDNA 6.2 vector expressing a YFP, and the negative control for lnc
least two independent experiments).
(B) Levels of lncLGR in nucleoplasm and chromatin fractions of mice liver tissue
(C) Immunoblotting analysis of purified hnRNPL proteins that are bound to biotin
(D) ChIP of pooled liver tissue samples frommice (n = 5) receiving control, hnRNPL
food withdrawal. The bands were amplified with specific primers for liver GCK, n
(E) Anti-hnRNPL immunoblotting analysis of proteins in immunoprecipitates of cro
antibody.
(F) Hepatic gene expressions in mice as described in Figure 4D (n = 7).
(G) A graphic model depicting the mechanism of hepatic GCK regulation by lncL
1874 Cell Reports 14, 1867–1875, March 1, 2016 ª2016 The Authorschanges in its neighbor genes and neither does the lncLGR
KD. Second, lncLGR overexpression reduces GCK expression.
Furthermore, the observation that lncLGR is expressed at a low
level, but has a functional effect is consistent with reported
function of another lncRNA, THRIL. The expression level of
THRIL in immune cells is very low, about eight copies per cell
and it regulates TNFa expression via binding hnRNPL as well
(Li et al., 2014). Nevertheless, lncRNA biology is a relatively
new research area and the relationship between lncRNA
expression levels and their functional importance has not
been fully defined, it remains to be determined if there are
more low copy lncRNAs that function in trans or lncLGR and
THRIL are just among the few exceptions.
Based on our findings here and a previous report showing the
interaction between lncLSTR and TDP-43 in lipid metabolism (Li
et al., 2015), recruitment of hnRNPs could be a general mecha-
nism for lncRNAs to transcriptionally regulate metabolic genes.
Cells could utilize lncRNAs induced by metabolic cues to recruit
a subset of abundant RNA-binding proteins to control specific
metabolic pathways. It is equally possible that some of the abun-
dant hnRNPs constitutively bind to DNA to generate a poised
state, whereby complexing with an inducible lncRNA serves as
a trigger to activate or suppress gene transcription. Thus,
lncRNAs might allow cells and organs to respond to environ-
mental or intrinsic signals by fine-tuning critical metabolic genes
like GCK.EXPERIMENTAL PROCEDURES
Adenovirus Production and In Vivo Adenovirus Administration
ShRNAs for lncLGR and hnRNPL were designed to act against mouse
sequences (lncLGR shRNA: GCACAGCTGTATTAGAATTGT and hnRNPL
shRNA: GCCTACGCGTTTAAATGTA). Hairpin template oligonucleotides
were synthesized by Integrated DNA Technologies and were subsequently
cloned into the adenovirus vector of the pAD/Block-it system (Invitrogen)
according to the manufacturer’s protocols. Overexpression constructs of
lncLGR, lncLGR D1–335, and mouse liver GCK were generated by PCR-
amplifying from mouse liver cDNA using the primers as: lncLGR-f:
TCTAAAAGCAAAGGAAGAAATGA-3, lncLGR-r: CACTGTCAAAACACTTTTA
ATGA and lncLGR D1–335-f: ATTCCAGGTGTTGAGCTGAGAAAG, GCK-f:
ATGGCTGTGGATACTACAAG, GCK-r: TCACTGGCCCAGCATGCAAC. PCR
products were subsequently cloned into the pAdv5 adenovirus vector for
virus packaging. Adenoviruses were amplified in HEK293A cells and purified
by CsCl gradient centrifugation. Purified viruses were desalted with
PD10 columns (GE Healthcare Life Sciences) and titered with Adeno-X Rapid
Titer Kit (Clontech). Adenoviruses were delivered into mice intravenously at
1–2 3 109 pfu/mouse. After 7 to 12 days, animal experiments were per-
formed and tissue samples and plasma were harvested for further analyses.ion
ted with vectors expressing hnRNPL, lncLGR, or both. The negative control for
LGR is the empty pcDNA 6.2 vector (n = 3 and the result is representative of at
samples (result of an independent experiment is also shown in Figure S2C).
ylated mouse GCK liver promoter fragments using an anti-hnRNPL antibody.
KD, or both hnRNPL KD and lncLGR overexpression adenoviruses after a 4 hr
euroendocrine GCK, or b-actin promoters.
sslinked mouse liver tissue samples shown in Figure 4D using an anti-hnRNPL
GR and hnRNPL. The error bars represent SEM and *p < 0.05.
Plasmid Constructs and Reporter Assay
Full-length hnRNPL expression clone (Myc-FLAG-tagged) was purchased
from OriGene (OriGene, MR208796). lncLGR was sub-cloned into pcDNA6.2,
and a yellow fluorescent protein (YFP) cDNA in pcDNA6.2 was used as a
control. Mouse GCK promoters were amplified by PCR using genomic DNA
(2 kb upstream) and cloned into a promoter-less pcDNA6.2 vector with a firefly
luciferase reporter. HEK293A cells were maintained in DMEM supplemented
with 10% Cosmic Calf Serum. Cells were transfected with the GCK reporter,
lncLGR, and hnRNPL or YFP vectors using Lipofectamine 2000 (Invitrogen),
and luciferase assays were performed 24 hr later using the Dual-Luciferase
Reporter Assay Kit (Promega). Transfection efficiency was measured by
normalization to Renilla luciferase activity expressed from a co-transfected
pTK-RL vector (Promega).
RNA Pull-Down Assay and Native RNA Immunoprecipitation
RNA pull-down was performed as described previously (Rinn et al., 2007).
Biotin-labeled RNAs were transcribed in vitro using the Biotin RNA Labeling
Mix and T7 RNA polymerase (Ambion) and purified with the RNeasy Mini Kit
(QIAGEN). Folded RNAs (1 ug) were added into 2 mg pre-cleared nuclear
lysates (supplemented with 0.2 mg/ml heparin, 0.2 mg/ml yeast tRNA, and
1 mM DTT) and incubated at 4C for 1 hr. There were 60 ml of washed Strep-
tavidin-coupled Dynabeads (Invitrogen) that were added to each binding
reaction and further incubated at 4C for 1 hr. Beads were washed five
times with RNA immunoprecipitation (RIP) buffer and heated at 70C for
10 min in 13 lithium dodecyl sulfate (LDS) loading buffer, and retrieved pro-
teins were visualized by SDS-PAGE and silver staining. The unique protein
bands shown in the sense RNA pull-down were identified by mass spectrom-
etry. For native RIP, 5 mg anti-hnRNPL antibody or mouse IgG were added
into 3 mg pre-cleared liver nuclear lysates and incubated at 4C for 2 hr.
There were 50 ml Dynabeads Protein G that were added and incubated for
1 hr at 4C with gentle rotation. Beads were washed for five times with
RIP buffer and resuspended in 1 ml of TRIzol. Co-precipitated RNAs were
isolated and analyzed by RT-PCR.
Statistical Analysis
Values represent mean ± SEM. Statistical significance of differences was
determined by Student’s t test or one-way ANOVA with Bonferroni’s post
hoc comparison where appropriate. p values less than 0.05 were considered
to be significant.
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